04 Jul 2016  |  North America
The Next Generation of Cancer Therapies
Immuno-oncology is based on the premise that tumors escape detection by the immune system, contributing to their growth and progression. Checkpoint inhibitor pathways act as the checks and balances that allow T-cells to recognize foreign substances or tumors. This global study looks at the immune-oncology therapeutics pipeline for checkpoint inhibi...
USD 6,000.00 save 25 %
27 Feb 2015  |  Global
Genetic Technology Alert. Drug Development in Oncology Using Personalized Medicine and Companion Diagnostics; Immunotherapeutic Candidate Development for Metastatic Melanoma; Next Generation Vaccinations for Infectious Diseases
This issue profiles drug development in oncology using personalized medicine and companion diagnostics, immunotherapeutic candidate development for metastatic melanoma, and next generation vaccinations for infectious diseases.
USD 187.50 save 25 %
24 Feb 2015  |  Asia Pacific
Future Impact of Emerging Technologies
The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0%...
28 Sep 2014  |  North America
Oncology Imaging and Diagnosis Technology Trends
Oncology diagnosis and biomarker technology is a multidisciplinary field within healthcare technologies. Imaging forms an essential part of cancer clinical protocols and is able to furnish morphological, structural, metabolic and functional information. Biomedical imaging is one of the main pillars of oncology imaging and cancer care. Modern medica...
USD 2,962.50 save 25 %
02 Nov 2012  |  North America
Volume 2: Patient Perspectives
Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. In Oncology, developers are interested in understanding the opportunities and parameters for delivery of drugs in outpatient settings, particularly the home. This is important for biotechnology products used in this area as companies seek to des...
USD 7,500.00 save 25 %
27 Sep 2012  |  North America
Volume 1: Oncologist and Infusion Nurse Perspectives
Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. This customer research was completed to understand trends, dynamics, and parameters specific to the delivery of drugs to cancer patients; identify physicians prescribing trends relative to delivery considerations; understand the role of reimburs...
USD 7,500.00 save 25 %
26 Sep 2011  |  Global
Radiation Oncology - Promising technologies providing a ray of hope for cancer.
This research service analyzes the funding scenario in radiation oncology industry sector and provides insights to investors for potential investments into promising technologies and offers strategic recommendations for firms for procuring funds. The study offers strategic analysis and insights on potential technologies worthy of investment and com...
26 Feb 2011  |  Europe
This research service provides a qualitative and quantitative analysis for interventional oncology technologies market in Europe. The rise in aging population and increased occurrence of cancer - liver , lung, kidney, breast and prostrate across the globe has increased the demand for the treatment of cancer using minimally invasive technologies. Th...
19 Dec 2009  |  Asia Pacific
Overview of Indian oncology market presents an all-encompassing research of Oncology markets for various cancers: Breast cancer, Lung Cancer, Ovarian cancer, Prostate cancer, Head and Neck cancer, Cervical cancer, Renal cell carcinoma and Pancreatic cancer. The research focuses on pharmaceutical industry spending in various segments of cancer treat...
05 Sep 2008  |  Africa
Research was carried out on the oncology healthcare industries in three countries, namely Kenya, Nigeria and Tanzania. A thorough PESTLE (political, economic, social, technology, legal and environmental) analysis was established for all the countries allowing for an accurate evaluation of the external factors impacting the oncology industries. Mar...